Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 177
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Quarterly Psychedelics Briefing: Q3 2026
Weekly Psychedelic Policy Briefing, September 21, 2026
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers
PT346 – Kevin Balktick – Horizons Northwest, The Psilocybin Services Act,...
MindMed Reports Second Quarter 2022 Financial Results and Business Highlights
Can Psilocybin Treat Obesity? New Evidence, Future Directions
Psilera’s New Compounds Show Potential for Significant Treatment Improvement in Depression...
Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders
PsyBio Therapeutics Announces Expansion of Patent Portfolio with Additional Global Patent...
Optimi Health To Launch Therapeutic Psilocybin Product In Partnership With Patient...
PT345 – Steve Thayer, Ph.D. – Vital Psychedelic Conversations
Buried Treasure: How Does Psilocybin Reduce Compulsivity?
Field Trip Health Ltd. Schedules Fiscal First Quarter 2023 Conference Call...
Load more